Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts.

[1]  D. Nelson,et al.  Serum cardiac troponin-T concentrations predict development of coronary artery disease in heart transplant patients. , 1998, Transplantation.

[2]  D. Nelson,et al.  Endothelial activation and development of coronary artery disease in transplanted human hearts. , 1997, JAMA.

[3]  M. Yacoub,et al.  Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. , 1997, Transplant immunology.

[4]  L. Wallentin,et al.  Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. , 1996, Circulation.

[5]  D. Nelson,et al.  Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. , 1995, The New England journal of medicine.

[6]  J. Mcintyre,et al.  Antiphospholipid antibodies in heart transplant recipients , 1995, Clinical cardiology.

[7]  P. Tipping,et al.  Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. , 1995, Atherosclerosis.

[8]  H. Winn,et al.  Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. , 1994, Journal of immunology.

[9]  W. Faulk,et al.  Vascular lesions in biopsy specimens devoid of cellular infiltrates: qualitative and quantitative immunocytochemical studies of human cardiac allografts. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  M. Yacoub,et al.  Anti-endothelial antibodies and coronary artery disease after cardiac transplantation , 1992, The Lancet.

[11]  H. Katus,et al.  S-troponin-T as a marker of ischemic myocardial injury. , 1992, Clinical chemistry.

[12]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  F J Pinto,et al.  Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening , 1991, Circulation.

[14]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[15]  S. Hunt,et al.  Acute myocardial infarction in cardiac transplant recipients. , 1989, The American journal of cardiology.

[16]  J. Schroeder,et al.  The spectrum of coronary artery pathologic findings in human cardiac allografts. , 1989, The Journal of heart transplantation.

[17]  V. Starnes,et al.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.

[18]  M. Khamashta,et al.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. , 1988, Clinical and experimental immunology.

[19]  M. Yacoub,et al.  Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease? , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  D C Naftel,et al.  Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  Marcus John Beasley,et al.  Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. , 1992, Clinical and experimental rheumatology.